2024-2025 Research Program Grant Opportunities
| Unrestricted Grants |
Up to five unrestricted grants will be awarded in 2025. Projects must be related to pulmonary, critical care, and sleep medicine. Applicants must first submit a letter of intent. All five grants will be awarded to the top-scoring projects regardless of specific research focus. |
| Diversity Grant |
One diversity grant will be awarded in 2025. This grant supports early-stage investigators from underrepresented populations in the US biomedical research enterprise, as defined by the NIH. Investigators may be working in pulmonary, critical care, and sleep medicine. Applicants must first submit a letter of intent via the unrestricted grant mechanism, where they may indicate that they meet the eligibility requirements and would like to be considered for the diversity grant. No longer accepting letters of intent in this cycle. |
| Partner Grants |
These grants are offered in partnership with the Research Program's partners to support targeted and disease-specific research grants. |
Review Process
Administrative Review
Research Program staff will review your application. If there are any problems or if guidelines have not been followed, your proposal will be un-submitted. We cannot accept changes to LOIs or applications once they have been submitted.
ATS uses Foundant Technologies for its online LOI and application.
- Please add @grantinterface.com to your address book or contacts to ensure you receive communications regarding your LOI and application.
Scientific Grant Review
The ATS Scientific Grant Review Committee (SGRC) is composed of nationally renowned pulmonary, sleep, and critical care researchers. The SGRC leads a rigorous, NIH-style review process to identify the most impactful research proposals.
Reviewers determine the overall impact of each application by assessing the quality of the investigator’s scientific background and research environment and evaluating each proposal’s overall significance, innovation, feasibility, and importance to patients.
Grant Review Process
For its unrestricted and diversity grants, the Research Program employs a two-stage process. Partner grants do not require a letter of intent and are reviewed at the full application stage.
1. Letter of Intent Stage- Two members of the SGRC review each LOI and provide an overall score.
- Researchers submitting LOIs with the highest scores are invited to submit full applications.
- Invitations to submit full applications will be made in late October.
- Full applications are reviewed by three SGRC members, who provide an overall impact score and comments.
- Applications are ranked by their average preliminary score. The lowest scoring applications are triaged and not discussed at the review.
- The remaining applications are discussed at the SGRC review meeting. The entire committee scores the applications.
- The applications are then ranked from lowest to highest average score. The SGRC recommends the top scoring application(s) in each grant category for funding.
Timeline
| Grant Portfolio Opens | July 17, 2024 |
| Letters of Intent Due* | September 16, 2024, 11:59 PM ET |
| Invitations to Applicants* | Late October 2024 |
| Full Applications Due | December 16, 2024, 11:59 PM ET |
| Award Notification | March 2025 |
| Grant Start Date | July 2025 |
*unrestricted/diversity grants only
The next cycle of Research Program grants will be launching in early 2025. Please check back here for more details.
Questions? Review the FAQs.
Contact the ATS Research Program.
